Toronto Dominion Bank Bellus Health Inc. Transaction History

Toronto Dominion Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$7.14 - $8.53 $11,316 - $13,520	-1,585 Reduced 18.14%	7,151 $51,000
Q4 2022 Feb 07, 2023	SELL	$8.22 - $10.76 $124,376 - $162,809	-15,131 Reduced 63.4%	8,736 $72,000
Q3 2022 Nov 09, 2022	BUY	$8.95 - $12.0 $154,154 - $206,688	17,224 Added 259.28%	23,867 $252,000
Q2 2022 Aug 11, 2022	BUY	$6.46 - $10.02 $19,657 - $30,490	3,043 Added 84.53%	6,643 $62,000
Q1 2022 May 09, 2022	BUY	$5.56 - $7.99 $19,960 - $28,684	3,590 Added 35900.0%	3,600 $25,000
Q4 2021 Feb 04, 2022	SELL	$5.26 - $8.3 $120 - $190	-23 Reduced 69.7%	10 $0
Q3 2021 Nov 08, 2021	SELL	$2.7 - $6.64 $159 - $391	-59 Reduced 64.13%	33 $0
Q2 2021 Aug 13, 2021	BUY	$3.11 - $4.61 $286 - $424	92 New	92 $0

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.